Advanced search
Publication Cover
Leukemia & Lymphoma Latest Articles
Submit an article Journal homepage
1,050
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy

Tara Cochranea Department of Haematology, Gold Coast University Hospital, Southport, Australia;b School of Medicine, Griffiths University, Parkwood, Queensland, AustraliaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2668-1399View further author information
ORCID Icon,
Alicia Enricoc Area Hematology, Hospital Italiano La Plata, Buenos Aires, ArgentinaORCID Iconhttps://orcid.org/0000-0002-1983-6145View further author information
ORCID Icon,
David Gomez-Almaguerd Hematology Service, Hospital Universitario, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, MexicoORCID Iconhttps://orcid.org/0000-0002-0460-6427View further author information
ORCID Icon,
Evgueniy Hadjieve Department of Internal Medicine, Medical University Sofia, University Hospital Alexandrovska, Sofia, BulgariaORCID Iconhttps://orcid.org/0000-0002-7811-6965View further author information
ORCID Icon,
Ewa Lech-Marandaf Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, PolandView further author information
,
Tamas Masszig Department of Internal Medicine and Haematology, Semmelweis University, Budapest, HungaryORCID Iconhttps://orcid.org/0000-0003-2322-9863View further author information
ORCID Icon,
Eugene Nikitinh Department of Hematology, Oncology and Chemotherapy, S. P. Botkin’s City Hospital, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0002-2490-1263View further author information
ORCID Icon,
Tadeusz Robaki Medical University of Lodz and Copernicus Memorial Hospital, Lodz, PolandORCID Iconhttps://orcid.org/0000-0002-3411-6357View further author information
ORCID Icon,
Robert Weinkovej Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital, Coast & Hutt Valley, Wellington, New Zealand;k Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New ZealandORCID Iconhttps://orcid.org/0000-0003-3645-7988View further author information
ORCID Icon,
Shang-Ju Wul Department of Internal Medicine, Division of Haematology, National Taiwan University Hospital, Taipei City, TaiwanView further author information
,
Beenish S. Manzoorm AbbVie, Inc., North Chicago, IL, USAORCID Iconhttps://orcid.org/0000-0002-0329-3465View further author information
ORCID Icon,
Todd Busmanm AbbVie, Inc., North Chicago, IL, USAView further author information
,
Madhavi Paim AbbVie, Inc., North Chicago, IL, USAView further author information
,
Viktor Komlosin AbbVie Schweiz AG, Cham, SwitzerlandView further author information
&
Mary Ann Andersono The Clinical Haematology Department of the Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia;p Division of Blood Cells and Blood Cancer, The Walter and Eliza Hall Institute, Parkville, Victoria, AustraliaORCID Iconhttps://orcid.org/0000-0002-3515-0215View further author information
ORCID Icon show all
Received 17 May 2023, Accepted 08 Aug 2023, Published online: 25 Aug 2023

References

  • Cochrane T, Enrico A, Gomez-Almaguer D, et al. Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial. Leuk Lymphoma. 2022;63(2):304–314. doi:10.1080/10428194.2021.1986217
  • Youron P, Singh C, Jindal N, et al. Quality of life in ­patients of chronic lymphocytic leukemia using the EORTC QLQ-C30 and QLQ-CLL17 questionnaire. Eur J Haematol. 2020;105(6):755–762. doi:10.1111/ejh.13503
  • Waweru C, Kaur S, Sharma S, et al. Health-related quality of life and economic burden of chronic lymphocytic leukemia in the era of novel targeted agents. Curr Med Res Opin. 2020;36(9):1481–1495. doi:10.1080/03007995.2020.1784120
  • Molica S. Quality of life in chronic lymphocytic leukemia: a neglected issue. Leuk Lymphoma. 2005;46(12):1709–1714. doi:10.1080/10428190500244183
  • Efficace F, Kemmler G, Vignetti M, et al. Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials – a systematic review to evaluate the added value in supporting ­clinical decision making. Eur J Cancer. 2008;44(11):1497–1506. doi:10.1016/j.ejca.2008.03.017

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.